Anthera Pharmaceuticals, Inc.
ANTH
Rank in Stocks
#34933
Anthera Pharmaceuticals, Inc., a biopharmaceutical enterprise, concentrates on... Anthera Pharmaceuticals, Inc., a biopharmaceutical enterprise, concentrates on developing and commercializing therapeutic solutions for conditions with significant unmet medical needs. The company's pipeline includes Sollpura, an investigational non-porcine pancreatic enzyme replacement therapy in Phase III clinical trials for individuals with exocrine pancreatic insufficiency. It is also advancing Blisibimod, currently in Phase II clinical evaluation for B-cell mediated autoimmune diseases, such as immunoglobulin A nephropathy (IgA nephropathy). Anthera holds licensing agreements with Amgen, Inc. and Eli Lilly and Company. Founded in 2004, the company's base of operations is in Houston, Texas.
Share Price
$0.0001
Last synced: 2026-11-06
Market Cap
$2.62K
Change (1 day)
0.00%
Change (1 year)
0.00%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Anthera Pharmaceuticals, Inc. (ANTH)
Category
Healthcare
Operating Margin for Anthera Pharmaceuticals, Inc. (ANTH)
Operating Margin as of November 2026 TTM: 0.00%
According to Anthera Pharmaceuticals, Inc.'s latest financial reports, its current operating margin (TTM) is 0.00%. At the end of 2017 the company had an operating margin of 0.00%.
Operating Margin history for Anthera Pharmaceuticals, Inc. from 2005 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | 0.00% | 0.00% |
| 2017 | 0.00% | -100.00% |
| 2016 | -39,432.41% | 3,463.61% |
| 2015 | -1,106.53% | 0.00% |
| 2014 | 0.00% | 0.00% |
| 2013 | 0.00% | 0.00% |
| 2012 | 0.00% | 0.00% |
| 2011 | 0.00% | 0.00% |
| 2010 | 0.00% | 0.00% |
| 2009 | 0.00% | 0.00% |
| 2008 | 0.00% | 0.00% |
| 2007 | 0.00% | 0.00% |
| 2006 | 0.00% | 0.00% |
| 2005 | 0.00% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 38.59% | - |
US
|
|
| -149.01% | - |
US
|
|
| 25.57% | - |
AU
|
|
| 31.23% | - |
BE
|
|
| 29.35% | - |
NL
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Anthera Pharmaceuticals, Inc.'s operating margin
What was Anthera Pharmaceuticals, Inc.'s operating margin in 2017?
In 2017, Anthera Pharmaceuticals, Inc.'s operating margin was 0.00%, compared with -39,432.41% in 2016.
How has Anthera Pharmaceuticals, Inc.'s operating margin changed since 2012?
From 2012 to 2017, Anthera Pharmaceuticals, Inc.'s operating margin was highest in 2017 (0.00%) and lowest in 2016 (-39,432.41%).
How does Anthera Pharmaceuticals, Inc.'s operating margin compare with similar companies?
Anthera Pharmaceuticals, Inc.'s operating margin (0.00%) is higher than that of 1 of the 5 similar companies listed above. The highest among them is Vertex Pharmaceuticals Incorporated, with 38.59%.